Asthma Exacerbation Clinical Trials

3 recruiting

Asthma Exacerbation Trials at a Glance

9 actively recruiting trials for asthma exacerbation are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Aurora, Beijing, and Chapel Hill. Lead sponsors running asthma exacerbation studies include DARTNet Institute, Massachusetts General Hospital, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse asthma exacerbation trials by phase

Treatments under study

About Asthma Exacerbation Clinical Trials

Looking for clinical trials for Asthma Exacerbation? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Asthma Exacerbation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Asthma Exacerbation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 4

45th Multicenter Airway Research Collaboration

AsthmaAsthma AcuteAsthma Exacerbation+1 more
Massachusetts General Hospital1,860 enrolled1 locationNCT07166939
Recruiting
Not Applicable

Evaluation of the Medentum Diagnostik Platform for Pediatric ENT Conditions and Asthma

Pediatric AsthmaAsthma ExacerbationAcute Otitis Media (AOM)+1 more
Medentum Innovations84 enrolled1 locationNCT07500532
Recruiting
Not Applicable

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

Biomarkers / BloodAsthma ExacerbationsEosinophil Blood Count
National Healthcare Group Polyclinics240 enrolled1 locationNCT07486401
Recruiting
Not Applicable

Pollution Intervention to Impact Kids Asthma Study

Childhood AsthmaAsthma ControlAsthma Exacerbation+1 more
University of Pittsburgh351 enrolled1 locationNCT07261423
Recruiting
Not Applicable

Bronchial Thermoplasty for Adults With Severe Asthma in the Biologic Era

Severe AsthmaAsthma ExacerbationsBronchial Thermoplasty
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)90 enrolled2 locationsNCT07292805
Recruiting
Phase 4

Individualizing Treatment for Asthma in Primary Care (Full Study)

AsthmaAsthma AttackAsthma Exacerbations
DARTNet Institute3,200 enrolled13 locationsNCT07052942
Recruiting
Not Applicable

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Allergic AsthmaAsthma AcuteThunderstorm Asthma+3 more
University of Melbourne530 enrolled1 locationNCT07055542
Recruiting
Not Applicable

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department

Moderate Asthma ExacerbationSevere Asthma Exacerbation
Poitiers University Hospital60 enrolled1 locationNCT05691218
Recruiting

A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype

Asthma Exacerbations
Peking University Third Hospital300 enrolled1 locationNCT06621056